|
AU2015200071A1
|
|
Bicyclic pyridines and analogs as sirtuin modulators
|
|
WO2012170494A1
|
|
Non-enzymatic synthesis of o-acetyl-adp-ribose and analogues thereof
|
|
WO2011116176A1
|
|
3-substitued imidazo (4, 5-b) pyridines and analogs as sirtuin modulators
|
|
CN102725291A
|
|
Bicyclic pyridines and analogs as sirtuin modulators
|
|
CN102414180A
|
|
8-substituted quinolines and related analogs as sirtuin modulators
|
|
UA104447C2
|
|
Thiazolopyridine sirtuin modulating compounds
|
|
AU2009333251A1
|
|
Phthalazinone and related analogs as sirtuin modulators
|
|
AU2009333543A1
|
|
Isoindolinone and related analogs as sirtuin modulators
|
|
EP2350051A1
|
|
Pyridine, bicyclic pyridine and related analogs as sirtuin modulators
|
|
CN102227417A
|
|
Chromenone analogs as sirtuin modulators
|
|
AU2009282076A1
|
|
Benzoxazoles, benzthiazoles and related analogs as sirtuin modulators
|
|
AU2009266889A1
|
|
Benzimidazoles and related analogs as sirtuin modulators
|
|
BRPI0913117A2
|
|
imidazopyridine and related analogues as sirtuin modulators
|
|
WO2009140562A1
|
|
Sirt1 polymorphic variants and methods of use thereof
|
|
AU2009243006A1
|
|
Quinolines and related analogs as sirtuin modulators
|
|
EP2249806A2
|
|
Resveratrol formulations
|
|
AU2008325148A1
|
|
Solubilized thiazolopyridines
|
|
CN101918371A
|
|
Amide derivatives as sirtuin modulators
|
|
WO2009014674A1
|
|
Heterocyclylamides as gut microsomal triglyceride transport protein inhibitors
|
|
TW200918542A
|
|
Sirtuin modulating compounds
|
